共 13 条
- [13] Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis International Journal of Clinical Oncology, 2015, 20 : 1018 - 1025